Northern Trust’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
MAM
DIG
Northern Trust's ARMP Position: Q2 2026 in Review
Northern Trust increased its Armata Pharmaceuticals (ARMP) stake by 264% in Q2 2026, buying an estimated $597K and bringing the position to 89,791 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #3634.
Northern Trust first reported a position in ARMP in Q1 2017 and has held it in 24 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.
- Northern Trust held 89,791 shares of Armata Pharmaceuticals worth $582K as of Q2 2026.
- Northern Trust bought 65,145 Armata Pharmaceuticals shares in Q2 2026, an estimated $597K.
- Armata Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3634 holding.
- Northern Trust first reported a position in Armata Pharmaceuticals in Q1 2017 and has held it in 24 quarters since.
- 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.